Table of Content

1 OTC Medicine Market Overview
1.1 Product Overview and Scope of OTC Medicine
1.2 OTC Medicine Segment by Type
1.2.1 Global OTC Medicine Market Value Comparison by Type (2024-2034)
1.2.2 Gastrointestinal Tract
1.2.3 Dermatology
1.2.4 Otolaryngology
1.2.5 Nutrition/Vitamins
1.2.6 Others
1.3 OTC Medicine Segment by Application
1.3.1 Global OTC Medicine Market Value by Application: (2024-2034)
1.3.2 Pharmacy
1.3.3 Hospital Pharmacy
1.3.4 Online Retailer
1.3.5 Others
1.4 Global OTC Medicine Market Size Estimates and Forecasts
1.4.1 Global OTC Medicine Revenue 2018-2029
1.4.2 Global OTC Medicine Sales 2018-2029
1.4.3 Global OTC Medicine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 OTC Medicine Market Competition by Manufacturers
2.1 Global OTC Medicine Sales Market Share by Manufacturers (2018-2024)
2.2 Global OTC Medicine Revenue Market Share by Manufacturers (2018-2024)
2.3 Global OTC Medicine Average Price by Manufacturers (2018-2024)
2.4 Global OTC Medicine Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of OTC Medicine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of OTC Medicine, Product Type & Application
2.7 OTC Medicine Market Competitive Situation and Trends
2.7.1 OTC Medicine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest OTC Medicine Players Market Share by Revenue
2.7.3 Global OTC Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 OTC Medicine Retrospective Market Scenario by Region
3.1 Global OTC Medicine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global OTC Medicine Global OTC Medicine Sales by Region: 2018-2029
3.2.1 Global OTC Medicine Sales by Region: 2018-2024
3.2.2 Global OTC Medicine Sales by Region: 2024-2029
3.3 Global OTC Medicine Global OTC Medicine Revenue by Region: 2018-2029
3.3.1 Global OTC Medicine Revenue by Region: 2018-2024
3.3.2 Global OTC Medicine Revenue by Region: 2024-2029
3.4 North America OTC Medicine Market Facts & Figures by Country
3.4.1 North America OTC Medicine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America OTC Medicine Sales by Country (2018-2029)
3.4.3 North America OTC Medicine Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe OTC Medicine Market Facts & Figures by Country
3.5.1 Europe OTC Medicine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe OTC Medicine Sales by Country (2018-2029)
3.5.3 Europe OTC Medicine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific OTC Medicine Market Facts & Figures by Country
3.6.1 Asia Pacific OTC Medicine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific OTC Medicine Sales by Country (2018-2029)
3.6.3 Asia Pacific OTC Medicine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America OTC Medicine Market Facts & Figures by Country
3.7.1 Latin America OTC Medicine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America OTC Medicine Sales by Country (2018-2029)
3.7.3 Latin America OTC Medicine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa OTC Medicine Market Facts & Figures by Country
3.8.1 Middle East and Africa OTC Medicine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa OTC Medicine Sales by Country (2018-2029)
3.8.3 Middle East and Africa OTC Medicine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global OTC Medicine Sales by Type (2018-2029)
4.1.1 Global OTC Medicine Sales by Type (2018-2024)
4.1.2 Global OTC Medicine Sales by Type (2024-2029)
4.1.3 Global OTC Medicine Sales Market Share by Type (2018-2029)
4.2 Global OTC Medicine Revenue by Type (2018-2029)
4.2.1 Global OTC Medicine Revenue by Type (2018-2024)
4.2.2 Global OTC Medicine Revenue by Type (2024-2029)
4.2.3 Global OTC Medicine Revenue Market Share by Type (2018-2029)
4.3 Global OTC Medicine Price by Type (2018-2029)
5 Segment by Application
5.1 Global OTC Medicine Sales by Application (2018-2029)
5.1.1 Global OTC Medicine Sales by Application (2018-2024)
5.1.2 Global OTC Medicine Sales by Application (2024-2029)
5.1.3 Global OTC Medicine Sales Market Share by Application (2018-2029)
5.2 Global OTC Medicine Revenue by Application (2018-2029)
5.2.1 Global OTC Medicine Revenue by Application (2018-2024)
5.2.2 Global OTC Medicine Revenue by Application (2024-2029)
5.2.3 Global OTC Medicine Revenue Market Share by Application (2018-2029)
5.3 Global OTC Medicine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Procter & Gamble
6.1.1 Procter & Gamble Corporation Information
6.1.2 Procter & Gamble Description and Business Overview
6.1.3 Procter & Gamble OTC Medicine Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Procter & Gamble OTC Medicine Product Portfolio
6.1.5 Procter & Gamble Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Corporation Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson OTC Medicine Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Johnson & Johnson OTC Medicine Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 GlaxoSmithKline Plc
6.3.1 GlaxoSmithKline Plc Corporation Information
6.3.2 GlaxoSmithKline Plc Description and Business Overview
6.3.3 GlaxoSmithKline Plc OTC Medicine Sales, Revenue and Gross Margin (2018-2024)
6.3.4 GlaxoSmithKline Plc OTC Medicine Product Portfolio
6.3.5 GlaxoSmithKline Plc Recent Developments/Updates
6.4 Abbott Laboratories
6.4.1 Abbott Laboratories Corporation Information
6.4.2 Abbott Laboratories Description and Business Overview
6.4.3 Abbott Laboratories OTC Medicine Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Abbott Laboratories OTC Medicine Product Portfolio
6.4.5 Abbott Laboratories Recent Developments/Updates
6.5 Amway Corporation
6.5.1 Amway Corporation Corporation Information
6.5.2 Amway Corporation Description and Business Overview
6.5.3 Amway Corporation OTC Medicine Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Amway Corporation OTC Medicine Product Portfolio
6.5.5 Amway Corporation Recent Developments/Updates
6.6 Bayer
6.6.1 Bayer Corporation Information
6.6.2 Bayer Description and Business Overview
6.6.3 Bayer OTC Medicine Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Bayer OTC Medicine Product Portfolio
6.6.5 Bayer Recent Developments/Updates
6.7 Aktienge
6.6.1 Aktienge Corporation Information
6.6.2 Aktienge Description and Business Overview
6.6.3 Aktienge OTC Medicine Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Aktienge OTC Medicine Product Portfolio
6.7.5 Aktienge Recent Developments/Updates
6.8 Sanofi
6.8.1 Sanofi Corporation Information
6.8.2 Sanofi Description and Business Overview
6.8.3 Sanofi OTC Medicine Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Sanofi OTC Medicine Product Portfolio
6.8.5 Sanofi Recent Developments/Updates
6.9 Pfizer
6.9.1 Pfizer Corporation Information
6.9.2 Pfizer Description and Business Overview
6.9.3 Pfizer OTC Medicine Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Pfizer OTC Medicine Product Portfolio
6.9.5 Pfizer Recent Developments/Updates
6.10 Reckitt Benckiser Group
6.10.1 Reckitt Benckiser Group Corporation Information
6.10.2 Reckitt Benckiser Group Description and Business Overview
6.10.3 Reckitt Benckiser Group OTC Medicine Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Reckitt Benckiser Group OTC Medicine Product Portfolio
6.10.5 Reckitt Benckiser Group Recent Developments/Updates
6.11 Church & Dwight
6.11.1 Church & Dwight Corporation Information
6.11.2 Church & Dwight OTC Medicine Description and Business Overview
6.11.3 Church & Dwight OTC Medicine Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Church & Dwight OTC Medicine Product Portfolio
6.11.5 Church & Dwight Recent Developments/Updates
6.12 Bayer HealthCare
6.12.1 Bayer HealthCare Corporation Information
6.12.2 Bayer HealthCare OTC Medicine Description and Business Overview
6.12.3 Bayer HealthCare OTC Medicine Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Bayer HealthCare OTC Medicine Product Portfolio
6.12.5 Bayer HealthCare Recent Developments/Updates
6.13 AstraZeneca
6.13.1 AstraZeneca Corporation Information
6.13.2 AstraZeneca OTC Medicine Description and Business Overview
6.13.3 AstraZeneca OTC Medicine Sales, Revenue and Gross Margin (2018-2024)
6.13.4 AstraZeneca OTC Medicine Product Portfolio
6.13.5 AstraZeneca Recent Developments/Updates
6.14 BioGaia
6.14.1 BioGaia Corporation Information
6.14.2 BioGaia OTC Medicine Description and Business Overview
6.14.3 BioGaia OTC Medicine Sales, Revenue and Gross Margin (2018-2024)
6.14.4 BioGaia OTC Medicine Product Portfolio
6.14.5 BioGaia Recent Developments/Updates
6.15 Bristol Myers Squibb
6.15.1 Bristol Myers Squibb Corporation Information
6.15.2 Bristol Myers Squibb OTC Medicine Description and Business Overview
6.15.3 Bristol Myers Squibb OTC Medicine Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Bristol Myers Squibb OTC Medicine Product Portfolio
6.15.5 Bristol Myers Squibb Recent Developments/Updates
6.16 Chr. Hansen
6.16.1 Chr. Hansen Corporation Information
6.16.2 Chr. Hansen OTC Medicine Description and Business Overview
6.16.3 Chr. Hansen OTC Medicine Sales, Revenue and Gross Margin (2018-2024)
6.16.4 Chr. Hansen OTC Medicine Product Portfolio
6.16.5 Chr. Hansen Recent Developments/Updates
6.17 Cipla
6.17.1 Cipla Corporation Information
6.17.2 Cipla OTC Medicine Description and Business Overview
6.17.3 Cipla OTC Medicine Sales, Revenue and Gross Margin (2018-2024)
6.17.4 Cipla OTC Medicine Product Portfolio
6.17.5 Cipla Recent Developments/Updates
6.18 CoLucid
6.18.1 CoLucid Corporation Information
6.18.2 CoLucid OTC Medicine Description and Business Overview
6.18.3 CoLucid OTC Medicine Sales, Revenue and Gross Margin (2018-2024)
6.18.4 CoLucid OTC Medicine Product Portfolio
6.18.5 CoLucid Recent Developments/Updates
6.19 Daiichi Sankyo
6.19.1 Daiichi Sankyo Corporation Information
6.19.2 Daiichi Sankyo OTC Medicine Description and Business Overview
6.19.3 Daiichi Sankyo OTC Medicine Sales, Revenue and Gross Margin (2018-2024)
6.19.4 Daiichi Sankyo OTC Medicine Product Portfolio
6.19.5 Daiichi Sankyo Recent Developments/Updates
6.20 Friggs
6.20.1 Friggs Corporation Information
6.20.2 Friggs OTC Medicine Description and Business Overview
6.20.3 Friggs OTC Medicine Sales, Revenue and Gross Margin (2018-2024)
6.20.4 Friggs OTC Medicine Product Portfolio
6.20.5 Friggs Recent Developments/Updates
6.21 DSM
6.21.1 DSM Corporation Information
6.21.2 DSM OTC Medicine Description and Business Overview
6.21.3 DSM OTC Medicine Sales, Revenue and Gross Margin (2018-2024)
6.21.4 DSM OTC Medicine Product Portfolio
6.21.5 DSM Recent Developments/Updates
6.22 Eisai
6.22.1 Eisai Corporation Information
6.22.2 Eisai OTC Medicine Description and Business Overview
6.22.3 Eisai OTC Medicine Sales, Revenue and Gross Margin (2018-2024)
6.22.4 Eisai OTC Medicine Product Portfolio
6.22.5 Eisai Recent Developments/Updates
6.23 Eli Lilly
6.23.1 Eli Lilly Corporation Information
6.23.2 Eli Lilly OTC Medicine Description and Business Overview
6.23.3 Eli Lilly OTC Medicine Sales, Revenue and Gross Margin (2018-2024)
6.23.4 Eli Lilly OTC Medicine Product Portfolio
6.23.5 Eli Lilly Recent Developments/Updates
6.24 Herbalife
6.24.1 Herbalife Corporation Information
6.24.2 Herbalife OTC Medicine Description and Business Overview
6.24.3 Herbalife OTC Medicine Sales, Revenue and Gross Margin (2018-2024)
6.24.4 Herbalife OTC Medicine Product Portfolio
6.24.5 Herbalife Recent Developments/Updates
6.25 Euradite
6.25.1 Euradite Corporation Information
6.25.2 Euradite OTC Medicine Description and Business Overview
6.25.3 Euradite OTC Medicine Sales, Revenue and Gross Margin (2018-2024)
6.25.4 Euradite OTC Medicine Product Portfolio
6.25.5 Euradite Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 OTC Medicine Industry Chain Analysis
7.2 OTC Medicine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 OTC Medicine Production Mode & Process
7.4 OTC Medicine Sales and Marketing
7.4.1 OTC Medicine Sales Channels
7.4.2 OTC Medicine Distributors
7.5 OTC Medicine Customers
8 OTC Medicine Market Dynamics
8.1 OTC Medicine Industry Trends
8.2 OTC Medicine Market Drivers
8.3 OTC Medicine Market Challenges
8.4 OTC Medicine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global OTC Medicine Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global OTC Medicine Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global OTC Medicine Market Competitive Situation by Manufacturers in 2022
Table 4. Global OTC Medicine Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global OTC Medicine Sales Market Share by Manufacturers (2018-2024)
Table 6. Global OTC Medicine Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global OTC Medicine Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market OTC Medicine Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of OTC Medicine, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of OTC Medicine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of OTC Medicine, Product Type & Application
Table 12. Global Key Manufacturers of OTC Medicine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global OTC Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in OTC Medicine as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global OTC Medicine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global OTC Medicine Sales by Region (2018-2024) & (K Units)
Table 18. Global OTC Medicine Sales Market Share by Region (2018-2024)
Table 19. Global OTC Medicine Sales by Region (2024-2029) & (K Units)
Table 20. Global OTC Medicine Sales Market Share by Region (2024-2029)
Table 21. Global OTC Medicine Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global OTC Medicine Revenue Market Share by Region (2018-2024)
Table 23. Global OTC Medicine Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global OTC Medicine Revenue Market Share by Region (2024-2029)
Table 25. North America OTC Medicine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America OTC Medicine Sales by Country (2018-2024) & (K Units)
Table 27. North America OTC Medicine Sales by Country (2024-2029) & (K Units)
Table 28. North America OTC Medicine Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America OTC Medicine Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe OTC Medicine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe OTC Medicine Sales by Country (2018-2024) & (K Units)
Table 32. Europe OTC Medicine Sales by Country (2024-2029) & (K Units)
Table 33. Europe OTC Medicine Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe OTC Medicine Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific OTC Medicine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific OTC Medicine Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific OTC Medicine Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific OTC Medicine Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific OTC Medicine Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America OTC Medicine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America OTC Medicine Sales by Country (2018-2024) & (K Units)
Table 42. Latin America OTC Medicine Sales by Country (2024-2029) & (K Units)
Table 43. Latin America OTC Medicine Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America OTC Medicine Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa OTC Medicine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa OTC Medicine Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa OTC Medicine Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa OTC Medicine Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa OTC Medicine Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global OTC Medicine Sales (K Units) by Type (2018-2024)
Table 51. Global OTC Medicine Sales (K Units) by Type (2024-2029)
Table 52. Global OTC Medicine Sales Market Share by Type (2018-2024)
Table 53. Global OTC Medicine Sales Market Share by Type (2024-2029)
Table 54. Global OTC Medicine Revenue (US$ Million) by Type (2018-2024)
Table 55. Global OTC Medicine Revenue (US$ Million) by Type (2024-2029)
Table 56. Global OTC Medicine Revenue Market Share by Type (2018-2024)
Table 57. Global OTC Medicine Revenue Market Share by Type (2024-2029)
Table 58. Global OTC Medicine Price (US$/Unit) by Type (2018-2024)
Table 59. Global OTC Medicine Price (US$/Unit) by Type (2024-2029)
Table 60. Global OTC Medicine Sales (K Units) by Application (2018-2024)
Table 61. Global OTC Medicine Sales (K Units) by Application (2024-2029)
Table 62. Global OTC Medicine Sales Market Share by Application (2018-2024)
Table 63. Global OTC Medicine Sales Market Share by Application (2024-2029)
Table 64. Global OTC Medicine Revenue (US$ Million) by Application (2018-2024)
Table 65. Global OTC Medicine Revenue (US$ Million) by Application (2024-2029)
Table 66. Global OTC Medicine Revenue Market Share by Application (2018-2024)
Table 67. Global OTC Medicine Revenue Market Share by Application (2024-2029)
Table 68. Global OTC Medicine Price (US$/Unit) by Application (2018-2024)
Table 69. Global OTC Medicine Price (US$/Unit) by Application (2024-2029)
Table 70. Procter & Gamble Corporation Information
Table 71. Procter & Gamble Description and Business Overview
Table 72. Procter & Gamble OTC Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Procter & Gamble OTC Medicine Product
Table 74. Procter & Gamble Recent Developments/Updates
Table 75. Johnson & Johnson Corporation Information
Table 76. Johnson & Johnson Description and Business Overview
Table 77. Johnson & Johnson OTC Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Johnson & Johnson OTC Medicine Product
Table 79. Johnson & Johnson Recent Developments/Updates
Table 80. GlaxoSmithKline Plc Corporation Information
Table 81. GlaxoSmithKline Plc Description and Business Overview
Table 82. GlaxoSmithKline Plc OTC Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. GlaxoSmithKline Plc OTC Medicine Product
Table 84. GlaxoSmithKline Plc Recent Developments/Updates
Table 85. Abbott Laboratories Corporation Information
Table 86. Abbott Laboratories Description and Business Overview
Table 87. Abbott Laboratories OTC Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Abbott Laboratories OTC Medicine Product
Table 89. Abbott Laboratories Recent Developments/Updates
Table 90. Amway Corporation Corporation Information
Table 91. Amway Corporation Description and Business Overview
Table 92. Amway Corporation OTC Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Amway Corporation OTC Medicine Product
Table 94. Amway Corporation Recent Developments/Updates
Table 95. Bayer Corporation Information
Table 96. Bayer Description and Business Overview
Table 97. Bayer OTC Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Bayer OTC Medicine Product
Table 99. Bayer Recent Developments/Updates
Table 100. Aktienge Corporation Information
Table 101. Aktienge Description and Business Overview
Table 102. Aktienge OTC Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. Aktienge OTC Medicine Product
Table 104. Aktienge Recent Developments/Updates
Table 105. Sanofi Corporation Information
Table 106. Sanofi Description and Business Overview
Table 107. Sanofi OTC Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Sanofi OTC Medicine Product
Table 109. Sanofi Recent Developments/Updates
Table 110. Pfizer Corporation Information
Table 111. Pfizer Description and Business Overview
Table 112. Pfizer OTC Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Pfizer OTC Medicine Product
Table 114. Pfizer Recent Developments/Updates
Table 115. Reckitt Benckiser Group Corporation Information
Table 116. Reckitt Benckiser Group Description and Business Overview
Table 117. Reckitt Benckiser Group OTC Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Reckitt Benckiser Group OTC Medicine Product
Table 119. Reckitt Benckiser Group Recent Developments/Updates
Table 120. Church & Dwight Corporation Information
Table 121. Church & Dwight Description and Business Overview
Table 122. Church & Dwight OTC Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Church & Dwight OTC Medicine Product
Table 124. Church & Dwight Recent Developments/Updates
Table 125. Bayer HealthCare Corporation Information
Table 126. Bayer HealthCare Description and Business Overview
Table 127. Bayer HealthCare OTC Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Bayer HealthCare OTC Medicine Product
Table 129. Bayer HealthCare Recent Developments/Updates
Table 130. AstraZeneca Corporation Information
Table 131. AstraZeneca Description and Business Overview
Table 132. AstraZeneca OTC Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. AstraZeneca OTC Medicine Product
Table 134. AstraZeneca Recent Developments/Updates
Table 135. BioGaia Corporation Information
Table 136. BioGaia Description and Business Overview
Table 137. BioGaia OTC Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. BioGaia OTC Medicine Product
Table 139. BioGaia Recent Developments/Updates
Table 140. Bristol Myers Squibb Corporation Information
Table 141. Bristol Myers Squibb Description and Business Overview
Table 142. Bristol Myers Squibb OTC Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. Bristol Myers Squibb OTC Medicine Product
Table 144. Bristol Myers Squibb Recent Developments/Updates
Table 145. Chr. Hansen Corporation Information
Table 146. Chr. Hansen Description and Business Overview
Table 147. Chr. Hansen OTC Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 148. Chr. Hansen OTC Medicine Product
Table 149. Chr. Hansen Recent Developments/Updates
Table 150. Cipla Corporation Information
Table 151. Cipla Description and Business Overview
Table 152. Cipla OTC Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 153. Cipla OTC Medicine Product
Table 154. Cipla Recent Developments/Updates
Table 155. CoLucid Corporation Information
Table 156. CoLucid Description and Business Overview
Table 157. CoLucid OTC Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 158. CoLucid OTC Medicine Product
Table 159. CoLucid Recent Developments/Updates
Table 160. Daiichi Sankyo Corporation Information
Table 161. Daiichi Sankyo Description and Business Overview
Table 162. Daiichi Sankyo OTC Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 163. Daiichi Sankyo OTC Medicine Product
Table 164. Daiichi Sankyo Recent Developments/Updates
Table 165. Friggs Corporation Information
Table 166. Friggs Description and Business Overview
Table 167. Friggs OTC Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 168. Friggs OTC Medicine Product
Table 169. Friggs Recent Developments/Updates
Table 170. DSM Corporation Information
Table 171. DSM Description and Business Overview
Table 172. DSM OTC Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 173. DSM OTC Medicine Product
Table 174. DSM Recent Developments/Updates
Table 175. Eisai Corporation Information
Table 176. Eisai Description and Business Overview
Table 177. Eisai OTC Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 178. Eisai OTC Medicine Product
Table 179. Eisai Recent Developments/Updates
Table 180. Eli Lilly Corporation Information
Table 181. Eli Lilly Description and Business Overview
Table 182. Eli Lilly OTC Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 183. Eli Lilly OTC Medicine Product
Table 184. Eli Lilly Recent Developments/Updates
Table 185. Herbalife Corporation Information
Table 186. Herbalife Description and Business Overview
Table 187. Herbalife OTC Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 188. Herbalife OTC Medicine Product
Table 189. Herbalife Recent Developments/Updates
Table 190. Euradite Corporation Information
Table 191. Euradite Description and Business Overview
Table 192. Euradite OTC Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 193. Euradite OTC Medicine Product
Table 194. Euradite Recent Developments/Updates
Table 195. Key Raw Materials Lists
Table 196. Raw Materials Key Suppliers Lists
Table 197. OTC Medicine Distributors List
Table 198. OTC Medicine Customers List
Table 199. OTC Medicine Market Trends
Table 200. OTC Medicine Market Drivers
Table 201. OTC Medicine Market Challenges
Table 202. OTC Medicine Market Restraints
Table 203. Research Programs/Design for This Report
Table 204. Key Data Information from Secondary Sources
Table 205. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of OTC Medicine
Figure 2. Global OTC Medicine Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global OTC Medicine Market Share by Type in 2022 & 2029
Figure 4. Gastrointestinal Tract Product Picture
Figure 5. Dermatology Product Picture
Figure 6. Otolaryngology Product Picture
Figure 7. Nutrition/Vitamins Product Picture
Figure 8. Others Product Picture
Figure 9. Global OTC Medicine Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 10. Global OTC Medicine Market Share by Application in 2022 & 2029
Figure 11. Pharmacy
Figure 12. Hospital Pharmacy
Figure 13. Online Retailer
Figure 14. Others
Figure 15. Global OTC Medicine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global OTC Medicine Market Size (2018-2029) & (US$ Million)
Figure 17. Global OTC Medicine Sales (2018-2029) & (K Units)
Figure 18. Global OTC Medicine Average Price (US$/Unit) & (2018-2029)
Figure 19. OTC Medicine Report Years Considered
Figure 20. OTC Medicine Sales Share by Manufacturers in 2022
Figure 21. Global OTC Medicine Revenue Share by Manufacturers in 2022
Figure 22. The Global 5 and 10 Largest OTC Medicine Players: Market Share by Revenue in 2022
Figure 23. OTC Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 24. Global OTC Medicine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 25. North America OTC Medicine Sales Market Share by Country (2018-2029)
Figure 26. North America OTC Medicine Revenue Market Share by Country (2018-2029)
Figure 27. United States OTC Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Canada OTC Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Europe OTC Medicine Sales Market Share by Country (2018-2029)
Figure 30. Europe OTC Medicine Revenue Market Share by Country (2018-2029)
Figure 31. Germany OTC Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. France OTC Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. U.K. OTC Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Italy OTC Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Russia OTC Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Asia Pacific OTC Medicine Sales Market Share by Region (2018-2029)
Figure 37. Asia Pacific OTC Medicine Revenue Market Share by Region (2018-2029)
Figure 38. China OTC Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Japan OTC Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. South Korea OTC Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. India OTC Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Australia OTC Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. China Taiwan OTC Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Indonesia OTC Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Thailand OTC Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Malaysia OTC Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Latin America OTC Medicine Sales Market Share by Country (2018-2029)
Figure 48. Latin America OTC Medicine Revenue Market Share by Country (2018-2029)
Figure 49. Mexico OTC Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Brazil OTC Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Argentina OTC Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Middle East & Africa OTC Medicine Sales Market Share by Country (2018-2029)
Figure 53. Middle East & Africa OTC Medicine Revenue Market Share by Country (2018-2029)
Figure 54. Turkey OTC Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Saudi Arabia OTC Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. UAE OTC Medicine Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. Global Sales Market Share of OTC Medicine by Type (2018-2029)
Figure 58. Global Revenue Market Share of OTC Medicine by Type (2018-2029)
Figure 59. Global OTC Medicine Price (US$/Unit) by Type (2018-2029)
Figure 60. Global Sales Market Share of OTC Medicine by Application (2018-2029)
Figure 61. Global Revenue Market Share of OTC Medicine by Application (2018-2029)
Figure 62. Global OTC Medicine Price (US$/Unit) by Application (2018-2029)
Figure 63. OTC Medicine Value Chain
Figure 64. OTC Medicine Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Distributors Profiles
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed